Skip to main content
Smart Investors Daily
Veeva Systems Inc. logo

NYSE · VEEV

Veeva Systems Inc.

Healthcare · Medical - Healthcare Information Services

$296.13

Up+$11.29 (+3.96%)

Updated Oct 10, 2026, 7:12 PM

SID Score

7.0/10

Composite research score

Smart Money

58/100

Neutral

Market cap
37.72B
P/E ratio
43.66
Dividend yield
0.00%
52-week range
$148.05 – $297.45
Volume
1.85M
Avg. volume
1.54M

Price performance · VEEV

VEEV price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

VEEV closed at $296.13 after 21 trading sessions, up 12.85% for the selected period.

Last close
$296.13
Period change
+12.85%
Period low
$260.21
Period high
$296.13
Daily close
View OHLC price history
VEEV OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$285.71$297.45$284.00$296.131.85M
Oct 8, 2026$282.13$285.245$279.0201$284.84922.1K
Oct 7, 2026$284.23$286.98$279.795$282.501.12M
Oct 6, 2026$285.34$289.87$282.2628$283.501.17M
Oct 5, 2026$275.00$283.47$274.00$283.451.32M
Oct 2, 2026$283.10$284.59$272.835$273.331.08M
Oct 1, 2026$291.40$291.40$281.79$281.93961.89K
Sep 30, 2026$277.85$288.41$275.70$285.451.76M
Sep 29, 2026$278.50$282.2424$273.92$278.571.1M
Sep 28, 2026$275.08$282.04$272.54$279.961.38M
Sep 25, 2026$276.84$282.81$275.91$280.681.74M
Sep 24, 2026$270.91$276.24$270.68$274.841.38M
Sep 23, 2026$263.25$272.18$262.995$270.751.43M
Sep 22, 2026$265.80$265.80$259.34$260.911.82M
Sep 21, 2026$260.00$264.42$257.87$261.311.2M
Sep 18, 2026$263.40$263.745$259.09$260.216M
Sep 17, 2026$263.44$266.71$260.45$263.751.12M
Sep 16, 2026$265.27$267.96$262.44$264.901.11M
Sep 15, 2026$260.80$272.3899$258.01$266.621.35M
Sep 14, 2026$264.93$267.4233$260.56$265.671.36M
Sep 11, 2026$261.81$263.69$259.54$262.40863.8K

Latest VEEV news

The latest Smart Investors Daily articles mentioning VEEV.

VEEV research

Overview

Company profile and research snapshot.

Company profile

Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$313.67
Implied upside
—
Analysts
40
VEEV recent ratings
DateFirmRatingTarget
Aug 28, 2026CitigroupNeutral—
Aug 27, 2026UBSNeutral—
Aug 27, 2026BarclaysOverweight—
Aug 27, 2026TD CowenBuy—
Aug 27, 2026Canaccord GenuityHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

AI Will Revolutionize Medicine. This Company Provides the Plumbing.

Veeva Systems is making that transformation happen. The Pleasanton, Calif.–based company develops software for biotechnology and pharmaceutical customers to manage everything from research and development and regulatory submissions to day-to-day commercial operations. Its software was originally built atop Salesforce but has since expanded to stand-alone applications.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.